Indeed, many previous studies have demonstrated that PEDF inhibits the proliferation and migration of nasopharyngeal carcinoma (20), pancreatic cancer (21), glioma (22), melanoma (23), and breast cancer (24) cells. Here, SERPINF1 is linked to breast carcinoma.